Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Equity (Unaudited)

v3.22.4
Condensed Consolidated Statements of Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings/ (Loss)
Accumulated Other Comprehensive Income/(Loss)
Employees
Common Stock
Executive Officer
Common Stock
Director
Common Stock
Beginning balance (in shares) at Mar. 31, 2021   33,225,808            
Beginning balance at Mar. 31, 2021 $ 378,872 $ 33 $ 231,322 $ 183,436 $ (35,919)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock in exercise of stock options (in shares)   8,100            
Issuance of common stock in exercise of stock options 97 $ 0 97          
Issuance of common stock (in shares)           23,858 42,326 7,368
Stock compensation expense 1,178   1,178          
Repurchase of employee stock units on vesting (548)   (548)          
Net income/(loss) (340)     (340)        
Foreign currency translation adjustment 4,195       4,195      
Other (64)       (64)      
Ending balance (in shares) at Jun. 30, 2021   33,307,460            
Ending balance at Jun. 30, 2021 383,390 $ 33 232,049 183,096 (31,788)      
Beginning balance (in shares) at Mar. 31, 2021   33,225,808            
Beginning balance at Mar. 31, 2021 378,872 $ 33 231,322 183,436 (35,919)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income/(loss) 11,407              
Ending balance (in shares) at Dec. 31, 2021   33,341,899            
Ending balance at Dec. 31, 2021 388,560 $ 33 233,555 194,843 (39,871)      
Beginning balance (in shares) at Jun. 30, 2021   33,307,460            
Beginning balance at Jun. 30, 2021 383,390 $ 33 232,049 183,096 (31,788)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock (in shares)           10,687 7,344 8,352
Stock compensation expense 1,246   1,246          
Repurchase of employee stock units on vesting (14)   (14)          
Net income/(loss) 477     477        
Foreign currency translation adjustment (7,625)       (7,625)      
Other 51   (1) 1 51      
Ending balance (in shares) at Sep. 30, 2021   33,333,843            
Ending balance at Sep. 30, 2021 377,525 $ 33 233,280 183,574 (39,362)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock (in shares)           52   8,004
Stock compensation expense 275   275          
Net income/(loss) 11,270     11,270        
Foreign currency translation adjustment (413)       (413)      
Other (97)   0 (1) (96)      
Ending balance (in shares) at Dec. 31, 2021   33,341,899            
Ending balance at Dec. 31, 2021 $ 388,560 $ 33 233,555 194,843 (39,871)      
Beginning balance (in shares) at Mar. 31, 2022 33,364,722 33,364,722            
Beginning balance at Mar. 31, 2022 $ 399,204 $ 33 234,549 203,528 (38,906)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock (in shares)           30,352 64,294 8,766
Stock compensation expense 1,193   1,193          
Repurchase of employee stock units on vesting (552)   (552)          
Net income/(loss) 6,556     6,556        
Foreign currency translation adjustment (5,152)     0 (5,152)      
Other 3     1 2      
Ending balance (in shares) at Jun. 30, 2022   33,468,134            
Ending balance at Jun. 30, 2022 $ 401,252 $ 33 235,190 210,085 (44,056)      
Beginning balance (in shares) at Mar. 31, 2022 33,364,722 33,364,722            
Beginning balance at Mar. 31, 2022 $ 399,204 $ 33 234,549 203,528 (38,906)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income/(loss) $ 25,965              
Ending balance (in shares) at Dec. 31, 2022 33,495,287 33,495,287            
Ending balance at Dec. 31, 2022 $ 411,504 $ 33 238,399 229,495 (56,423)      
Beginning balance (in shares) at Jun. 30, 2022   33,468,134            
Beginning balance at Jun. 30, 2022 401,252 $ 33 235,190 210,085 (44,056)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock (in shares)           5,544   9,930
Stock compensation expense 1,251   1,251          
Repurchase of employee stock units on vesting (34)   (34)          
Net income/(loss) 10,984     10,984        
Foreign currency translation adjustment (17,811)       (17,811)      
Other 116   0 0 116      
Ending balance (in shares) at Sep. 30, 2022   33,483,608            
Ending balance at Sep. 30, 2022 395,758 $ 33 236,407 221,069 (61,751)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock (in shares)           512   11,167
Stock compensation expense 1,994   1,994          
Repurchase of employee stock units on vesting (2)   (2)          
Net income/(loss) 8,425     8,425        
Foreign currency translation adjustment 5,403       5,403      
Other $ (74)     1 (75)      
Ending balance (in shares) at Dec. 31, 2022 33,495,287 33,495,287            
Ending balance at Dec. 31, 2022 $ 411,504 $ 33 $ 238,399 $ 229,495 $ (56,423)